Simultaneous cardiac mechanics and phosphorus‐31 NMR spectroscopy during myocardial ischemia and reperfusion in the intact dog
- 1 January 1991
- journal article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 17 (1) , 41-52
- https://doi.org/10.1002/mrm.1910170109
Abstract
To investigate the high‐energy phosphate metabolic correlates of left ventricular (LV) dysfunction during the onset and recovery from severe, global myocardial ischemia in vivo, seven preinstrumented closed‐chest dogs had ECG‐gated phosphorus‐31 (31P) NMR‐spectroscopy (NMR‐S) studies performed and LV micromanometer and sonomicrometer data measured before, during, and every 5 min following severe occlusive global myocardial ischemia. Ischemic LV + dP/dtmax fell from 2396 ± 576 mm Hg/s at baseline to 2185 ± 478 mm Hg/s (p < 0.05) and did not normalize until after 30 min of reperfusion. LV ejection fraction (EF) decreased significantly (0.32 ± 0.07 EF units to 0.12 ± 0.13 EF units; P < 0.05) and did not recover by 30 min of reperfusion (0.27 ±0.09 units; P < 0.05 vs baseline). Simultaneous 31P NMR‐S studies demonstrated excellent β ‐ATP signal‐to‐noise (10 ± 4:1). Myocardial acidosis occurred during global ischemia (ApH = −0.22 ± 0.23 units; p < 0.05), with recovery at 30 min of reperfusion. Inorganic phosphate/ phosphocreatine ratio (Pi/PCr) increased significantly during ischemia (0.46 ± 0.07 to 0.61 ± 0.07; P < 0.05), with delayed normalization of this ratio at 30 min of reperfusion. β‐ATP peak area did not change during ischemia. Pi/PCr and LV contractility ( + dP/ dtmax ) were significantly correlated at baseline (r = −0.70) and during global ischemia (r = −0.78; p < 0.01), but not during recovery (r = 0.006; p = NS). Therefore, the simultaneous evaluation of high‐fidelity hemodynamic data and topical 31P NMR‐S can be performed in the intact State. © 1991 Academic Press, Inc.Keywords
This publication has 28 references indexed in Scilit:
- Transmural metabolite distribution in regional myocardial ischemia as studied with31p NMRMagnetic Resonance in Medicine, 1989
- Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heartJournal of the American College of Cardiology, 1988
- Regional myocardial blood flow, function and metabolism using phosphorus-31 nuclear magnetic resonance spectroscopy during ischemia and reperfusion in dogsJournal of the American College of Cardiology, 1987
- Nucleotide Metabolism and Cellular Damage in Myocardial IschemiaAnnual Review of Physiology, 1985
- Energy metabolism in reperfused heart muscle: Metabolic correlates to return of functionJournal of the American College of Cardiology, 1985
- Noninvasive Study of High-Energy Phosphate Metabolism in Human Heart by Depth-Resolved 31 P NMR SpectroscopyScience, 1985
- Diagnosis and therapeutic evaluation of a pediatric case of cardiomyopathy using phosphorus-31 nuclear magnetic resonance spectroscopyJournal of the American College of Cardiology, 1985
- Effects of recurrent ischemia on myocardial high energy phosphate content in canine heartsBasic Research in Cardiology, 1984
- Mechanisms of ischemic myocardial cell damage assessed by phosphorus-31 nuclear magnetic resonance.Circulation, 1982
- Physiologic basis for assessing critical coronary stenosisThe American Journal of Cardiology, 1974